Barbara Ryan, Director at MiNK Therapeutics, Inc. (INKT), sold 500 shares at $10.83 ($5K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($5k) by Director — this insider has traded INKT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.86 | 400 | $4K | 80.0% |
| 2 | $10.83 | 100 | $1K | 20.0% |
| Total | $10.85 avg | 500 | $5K | 100% |
| Filing → |
| INDV | BUY | 2026-03-11 | $1K | — | Filing → |
| INKT | SELL | 2026-03-11 | $36K | — | Filing → |
| INDV | BUY | 2026-01-07 | $27K | — | Filing → |